-
Nortriptyline treatment of post-stroke depression: a double-blind study.
The efficacy of nortriptyline in the treatment of post-stroke depression was assessed by a double-blind study in thirty-four patients. Half of the patients had major depression. There was a significantly greater improvement in depression in patients treated with nortriptyline than in a similar group of placebo-treated patients. Depression was measured by the Hamilton depression scale, Zung depression scale, present state examination, and an overall depression scale. Successfully treated patients had serum nortriptyline levels in the therapeutic range. Post-stroke depressions are common, severe, and longstanding, and the demonstrated efficacy of nortriptyline provides an important addition to the treatments available for stroke patients.
PMID: 6141377 [PubMed - indexed for MEDLINE]
-
Cited by 11 PubMed Central articles
-
Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends.
Crystal S, Sambamoorthi U, Walkup JT, Akincigil A.
J Am Geriatr Soc. 2003 Dec; 51(12):1718-28.
[J Am Geriatr Soc. 2003]
-
Unipolar late-onset depression: A comprehensive review.
Fountoulakis KN, O'Hara R, Iacovides A, Camilleri CP, Kaprinis S, Kaprinis G, Yesavage J.
Ann Gen Hosp Psychiatry. 2003 Dec 16; 2(1):11. Epub 2003 Dec 16.
[Ann Gen Hosp Psychiatry. 2003]
-
Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.
Palomäki H, Kaste M, Berg A, Lönnqvist R, Lönnqvist J, Lehtihalmes M, Hares J.
J Neurol Neurosurg Psychiatry. 1999 Apr; 66(4):490-4.
[J Neurol Neurosurg Psychiatry. 1999]
- » See all...